HGH Fragment 176-191 5mg

HGH Fragment 176-191 (commonly referred to as Fragment 176-191 or AOD-9604 derivative) is a modified synthetic peptide representing the C-terminal region (amino acids 176 through 191) of human growth hormone (hGH).

This specific domain is responsible for the lipolytic (fat-burning) properties of full-length growth hormone. By isolating only the lipolytic domain, Fragment 176-191 triggers fat oxidation and inhibits lipogenesis without impacting insulin sensitivity, blood glucose levels, or cell proliferation, avoiding the diabetogenic side effects associated with full recombinant hGH. The 5mg vial provides a higher-capacity formulation ideal for extended fat loss protocols.

Key Benefits & Applications

• Targeted Fat Loss (Lipolysis): Stimulates lipolysis (breakdown of triglycerides into free fatty acids) specifically in stubborn visceral and subcutaneous adipose tissues.

• Inhibition of Lipogenesis: Prevents the conversion and accumulation of new dietary fats into adipose stores.

• Preservation of Glycemic Control: Does not induce insulin resistance, hyperglycemia, or blood sugar spikes, making it safer for metabolism than full-length hGH.

• Lean Tissue Preservation: Promotes fat oxidation for energy utilization without catabolizing existing muscle tissue.

• No Impact on IGF-1 Levels: Does not elevate circulating IGF-1, eliminating risks associated with organ growth or systemic cell proliferation.